Skip to content

SCHEDULE 13DAccepted Feb 12, 6:48 PM ET

Eikon Therapeutics, Inc. SCHEDULE 13D

Column Group IV GP, LP

sec.gov(opens the filing on sec.gov)

Accepted (ET)

6:48 PM

Feb 12, 2026

Filed

Feb 12, 2026

Documents

2

Size

140.4 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.